Empagliflozin Alleviates Atherosclerosis Progression by Inhibiting Inflammation and Sympathetic Activity in a Normoglycemic Mouse Model - Concepedia

Concepedia

Publication | Open Access

Empagliflozin Alleviates Atherosclerosis Progression by Inhibiting Inflammation and Sympathetic Activity in a Normoglycemic Mouse Model

DOI Full Paper Access

39

Citations

26

References

2021

Year

Yihai Liu, Mingyue Wu, Biao Xu, Lina Kang

Journal of Inflammation Research

Abstract

Empagliflozin could prevent atherosclerosis by repressing inflammation and sympathetic activity.

References

	Year	Citations

Page 1